Cobalt Capital Management’s Boston Scientific BSX Stock Holding History

Cobalt Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-453,000	Closed	-$10.8M	–	51
2016 Q3	$10.8M	Sell	453,000 -627,000	-58%	-$15M	1.64%	26
2016 Q2	$25.2M	Sell	1,080,000 -692,000	-39%	-$15M	3.36%	9
2016 Q1	$33.3M	Buy	1,772,000 +20,000	+1%	+$351K	4.19%	8
2015 Q4	$32.3M	Buy	1,752,000 +92,500	+6%	+$1.66M	4.14%	6
2015 Q3	$27.2M	Buy	1,659,500 +244,500	+17%	+$4.18M	2.64%	14
2015 Q2	$25M	Buy	1,415,000 +113,000	+9%	+$2.02M	2.32%	16
2015 Q1	$23.1M	Buy	+1,302,000	New	+$20.6M	2.47%	13
2013 Q3	–	Sell	-100,000	Closed	-$927K	–	58
2013 Q2	$927K	Buy	+100,000	New	+$848K	0.09%	58

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cobalt Capital Management's BSX Position: Q4 2016 in Review

Cobalt Capital Management sold out of Boston Scientific (BSX) in Q4 2016, closing a stake of 453,000 shares — an estimated $10.8M sold.

Cobalt Capital Management first reported a position in BSX in Q2 2013 and held it in 8 quarters. The position peaked at $33.3M in Q1 2016. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

Cobalt Capital Management reported no remaining Boston Scientific position as of Q4 2016 after selling out during the quarter.
Cobalt Capital Management sold 453,000 Boston Scientific shares in Q4 2016, an estimated $10.8M.
Cobalt Capital Management first reported a position in Boston Scientific in Q2 2013 and held it in 8 quarters.
Cobalt Capital Management's Boston Scientific position peaked at $33.3M in Q1 2016.
556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on Cobalt Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.